February 2014, Wiley-Blackwell
Dementia is a devastating diagnosis for patients
Dementia comes in many forms that can be hard to differentiate.
Arriving at an accurate diagnosis without subjecting an already
wary patient to unnecessary tests requires clinical acumen.
Identifying the correct dementia, and determining a probable
prognosis, allows agreement on appropriate management and care with
patients and their carers.
But how much testing is needed? What do the tests tell you? What management options are available?
Dementia provides a progressive approach to help you identify and manage the many forms of this complex and devastating disease. Dr Quinn has assembled a team of expert neurologists and gerontologists to provide the foundation knowledge you need to develop the clinical wisdom for effective dementia care. Dementia clearly explains the diagnosis, investigations and management for
- Normal pressure hydrocephalus
- Mild cognitive impairment
- Alzheimer’s disease
- Vascular dementia
- Dementia with Lewy bodies
- Fronto-temporal dementia
Clinical in approach, practical in execution, Dementia helps you diagnose and treat your patients more effectively.
Series Foreword ix
Chapter 1 Diagnosis and Differential Diagnosis of Dementia 1
Chapter 2 Rapidly Progressive Dementia and its Mimics 15
Amy May Lin Quek and Andrew McKeon
Chapter 3 Young Onset Dementia: How Much Diagnostic Testing is Enough? 35
Anahita Adeli and Keith A. Josephs
Chapter 4 An Approach to the Problem of Normal Pressure Hydrocephalus 55
Chapter 5 Depression: Cause or Complication of Cognitive Decline? 67
David Mansoor, Sahana Misra, and Linda Ganzini
Chapter 6 Mild Cognitive Impairment 77
Ranjan Duara, David A. Loewenstein, Clinton Wright, Elizabeth Crocco, and Daniel Varon
Chapter 7 After the Diagnosis: Continuing Neurological Care of the Outpatient with Dementia 97
Anne M. Lipton
Chapter 8 Using Psychotropic Medications to Manage Problem Behaviors in Dementia 111
Lucy Y. Wang and Murray A. Raskind
Chapter 9 Palliative Care in Advanced Dementias 121
Ira Byock and Cory Ingram
Chapter 10 Ethical, Legal, and Social Issues in Dementia 137
Amy Y. Tsou and Jason Karlawish
Chapter 11 Assessing Outcomes in Dementia Care 151
Joel Mack, Amie Peterson, and Joseph Quinn
Chapter 12 Primary Prevention of Dementia 163
Dr. Quinn has served as a neurologist clinician in the Oregon Alzheimer's Disease Center since 1994 and has served as Director of the Genetics and Biomarkers Core since 2007.
Dr. Quinn's overall research focus is on developing strategies for treating and preventing Alzheimer's disease and other dementias. Specific research projects range from animal studies testing experimental agents, up to large national multi-center clinical trials of experimental drugs for dementing illnesses. The translation of ideas from the laboratory to the clinic is a particular interest, which is served in part by the Biomarkers core of the Oregon Alzheimer's Center. The Biomarkers Core helps develop blood tests and other disease markers for use in "proof of concept" clinical trials which are necessary to move treatment ideas from animal models to human subjects.